Analytical method development
Every number in a development project comes from a method, and a process is only as trustworthy as the method behind it. We build methods that separate what has to be separated, then prove they keep doing it — in development, in transfer and in routine production.
Talk to us about your methodThree things a method has to do
Our analytical team works across the needs of the chemical and pharmaceutical industry, at every stage from method development to the standardisation of protocols in production.
Support development
A number you can compare between runs. Without one, an optimisation round measures a difference in assay rather than a difference in process. This is also where in-process controls (IPC) belong — the checks that run alongside production, not only downstream of it.
Release the product
Identity, assay, purity and impurity profile against a specification, with the method validated to the standard your file needs.
Survive the transfer
The same method, run by another laboratory on another instrument, giving the same result. This is where most methods fail, so it is designed for from the first day.
How a project runs
Three stages. How long each takes depends on the matrix and on how much has to be separated from how little — we size it after the first conversation, not before.
Development
The separation first: column chemistry, mobile phase, gradient and detection chosen against your matrix and your impurities, not against a generic standard. Then the working parameters — range, sensitivity, run time — set to what the method will actually be used for.
Validation
Specificity, linearity, accuracy, precision under repeatability and intermediate conditions, limits of detection and quantification, range and robustness. Stability-indicating where the product needs it, with forced degradation to prove the method sees what it must see.
Transfer and routine
The method written so that someone else can run it, transferred to your laboratory or your manufacturer, and standardised for the production phase, in-process controls included. Stability studies where the programme requires them.
What a method has to demonstrate
These are the endpoints a method is judged on, and the ones we report.
- Specificity — the analyte resolved from matrix, excipients and every impurity that matters
- Linearity and range — over the concentrations the method will actually see, not a convenient window
- Accuracy — recovery on spiked real matrix, not on standard in clean solvent
- Precision — repeatability and intermediate precision, with the spread declared
- LOD and LOQ — established experimentally rather than asserted
- Robustness — deliberate small changes in flow, temperature, pH and mobile phase composition
- Stability-indicating capability — forced degradation, and the degradants resolved from the analyte
- Transferability — the same result in another laboratory, on another instrument, in another pair of hands
The laboratory behind it
Equipment
| Liquid chromatography | HPLC, analytical and semi-preparative, and UPLC, with UV and diode array, fluorescence and refractive index detection |
| Gas chromatography | GC with mass spectrometer detector, headspace analysis and autosampler |
| Separation chemistries | Reversed phase (C18, C8, C4), normal phase (silica, alumina), bonded phases (amino, diol, CN, PFP, phenyl, hexylphenyl), polymeric stationary phases, ion exchange (SAX, SCX, CEX, WCX), gel filtration and chiral phases |
| Techniques in partnership | Nuclear magnetic resonance (NMR), managed through a qualified external partner |
| Other instrumentation | Spectrophotometers, titrators and ÄKTA chromatography systems |
What you take away
| Method | The method itself, written so that it can be run by someone other than the person who built it |
| Dossier | Development and validation data and results, in the form your technical file needs |
| Routine support | Standardisation for the production phase, and stability studies when the programme needs them |
Plant vesicles too. For plant-derived extracellular vesicles we measure particle concentration and size distribution by NTA, protein and lipid content, and matrix contaminants. Plant-derived extracellular vesicles →
Start with what has to be measured
Tell us the molecule, the matrix and the purpose — development, release or transfer. We will tell you what the method would have to do and what the first stage would look like.
Talk to us about your method